Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Systagenix Wound Management Ltd.

Division of 3M Co.
www.systagenix.com

Latest From Systagenix Wound Management Ltd.

Plastic Surgery Market: Fat Grafting Grabs A Hefty Slice Of The Plastics Pie

Fat, fillers, and a "funnel" that may minimize a common cause of breast implant complications are among the hot topics in both aesthetic and reconstructive plastic surgery. Meanwhile, the acquisition by Actavis of Allergan – a leading player in the aesthetics market with BOTOX and breast implants – has the combined company poised for long-term double-digit revenue and earnings growth.

Medical Device North America

News Briefs: Vertebral Augmentation Alternative; ReCor Recommits To Renal Denerv

Benvenue cleared for vertebral augmentation alternative. ReCor recommits to renal denervation. Spine surgery firm plans IPO. More news.

Medical Device

News Briefs: MAKO Purchase; KCI Merger; Medicare Competitive Bidding Update

MAKO plans to acquire Pipeline Biomedical Holdings before it becomes part of Stryker. KCI, LifeCell and Systagenix to merge. Medicare announces rates for DME competitive bidding recompete. More news.

Medical Device Regulation

Deals In Depth: June/July 2013

In a regional deal, AstraZeneca licensed rights to FibroGen’s renal candidate in an alliance worth $815 million; Elan finally agreed to an $8.3 billion takeover by Perrigo; biopharma financing totaled $7.1 billion and $2 billion in June and July, respectively, while device fundraising reached $325 million and $316 million in the same months.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Medical Devices
    • Biomaterials
  • Therapeutic Areas
  • Wound Healing & Tissue Repair
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • 3M Co.
  • Senior Management
  • Peter Huntley, SVP, Head
  • Contact Info
  • Systagenix Wound Management Ltd.
    Phone: 1293 842000
    2 City Pl., Beehive Ring Rd.
    Gatwick, RH6 0PA
    UK
Advertisement
Advertisement
UsernamePublicRestriction

Register